Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Chen, Li ^a   Wu, Yuan Yuan ^a   Liu, Peigen ^b   Wang, Jianli ^b   Wang, Guilan ^a   Qin, Jin ^a   Zhou, Jiaming ^a   Zhu, Jianwei ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Cervical cancer; E6 E7 oncoproteins; HPV18; VEGF

Indexed keywords

MESSENGER RNA; SHORT HAIRPIN RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; DOWN REGULATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR GROWTH; TUMOR XENOGRAFT; UTERINE CERVIX CANCER;

EID: 84655176635     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9690-1     Document Type: Article

References (39)

1. H Zur Hausen 2002 Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 342 350 (Pubitemid 37328947)
2. P Hawley-Nelson KH Vousden NL Hubbert DR Lowy JT Schiller 1989 HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes EMBO J 8 3905 3910 (Pubitemid 20016074)
3. K Münger WC Phelps V Bubb PM Howley R Schlegel 1989 The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes J Virol 63 4417 4421 (Pubitemid 19229441)
4. M Scheffner BA Werness JM Huibregtse AJ Levine PM Howley 1990 The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1129 1136 (Pubitemid 120035062)
5. JM Huibregtse M Scheffner PM Howley 1993 Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins Mol Cell Biol 13 4918 4927 (Pubitemid 23220397)
6. M Thomas C Chiang 2005 E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation Mol Cell 17 251 264 (Pubitemid 40138619)
7. DV Heck CL Yee PM Howley K Münger 1992 Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc Natl Acad Sci USA 89 4442 4446
8. N Dyson P Guida K Münger E Harlow 1992 Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins J Virol 66 6893 6902
9. J Folkman 1995 Clinical applications of research on angiogenesis N Engl J Med 333 1757 1763 (Pubitemid 26009687)
10. Folkman J. Tumor angiogenesis. In: Mendelssohn J, editor. The molecular basis of cancer. Philadelphia, 1995. pp 206-235.
11. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57 70 (Pubitemid 30046295)
12. RK Jain 2003 Molecular regulation of vessel maturation Nat Med 9 685 693 (Pubitemid 36749217)
13. N Ferrara T Davis-Smyth 1997 The biology of vascular endothelial growth factor Endocr Rev 18 4 25 (Pubitemid 27076453)
14. E Tischer 1991 The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing J Biol Chem 266 11947 11954
15. N Rahimi V Dayanir K Lashkari 2000 Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells J Biol Chem 275 16986 16992 (Pubitemid 30398939)
16. TH Lee HK Avraham S Jiang S Avraham 2003 Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability J Biol Chem 278 5277 5284 (Pubitemid 36801042)
17. RK Jain 2001 Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy Nat Med 7 987 989 (Pubitemid 32937367)
18. RK Jain 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58 62 (Pubitemid 40093472)
19. P Baluk 2004 Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways Am J Pathol 165 1071 1085 (Pubitemid 39297715)
20. MR Mancuso 2006 Rapid vascular regrowth in tumors after reversal of VEGF inhibition J Clin Invest 116 2610 2621 (Pubitemid 44511625)
21. N Clere 2007 The human papillomavirus type 18 E6 oncoprotein induces vascular endothelial growth factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism Exp Cell Res 313 3239 3250 (Pubitemid 47284068)
22. NJ Caplen 2003 RNAi as a gene therapy approach Expert Opin Biol Ther 3 575 586 (Pubitemid 36834791)
23. K Butz 2003 siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells Oncogene 22 5938 5945 (Pubitemid 37175872)
24. G Soufla 2005 VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix Cancer Lett 221 105 118 (Pubitemid 40387914)
25. O López-Ocejo 2000 Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner Oncogene 19 4611 4620
26. R Ravi 2000 Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha Genes Dev 14 34 44 (Pubitemid 30051577)
27. S Pal K Datta D Mukhopadhyay 2001 Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma Cancer Res 61 6952 6957 (Pubitemid 32896524)
28. E Toussaint-Smith DB Donner A Roman 2004 Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors Oncogene 23 2988 2995 (Pubitemid 38648189)
29. H Pan AE Griep 1994 Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development Genes Dev 9 2157 2169
30. RA DeFilippis EC Goodwin L Wu D DiMaio 2003 Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells J Virol 77 1551 1563 (Pubitemid 36055574)
31. M Thomas L Banks 1999 The role of the E6-p53 interaction in the molecular pathogenesis of HPV Oncogene 18 7690 7700 (Pubitemid 30052696)
32. V Bechtold P Beard K Raj 2003 Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA J Virol 77 2021 2028 (Pubitemid 36110014)
33. MJ Ferber 2003 Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma Oncogene 22 7233 7242 (Pubitemid 37378556)
34. RS Mathur SP Mathur 2005 Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers Gynecol Oncol 97 206 213 (Pubitemid 40403696)
35. JE Nör J Christensen DJ Mooney PJ Polverini 1999 Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression Am J Pathol 154 375 384 (Pubitemid 29094088)
36. K Niemöller 2003 Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III J Cancer Res Clin Oncol 129 234 238 (Pubitemid 36713799)
37. R Takahashi 2003 Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach Oncology 64 266 274 (Pubitemid 36438812)
38. S Onogawa 2002 Clinical significance of angiogenesis in rectal carcinoid tumors Oncol Rep 9 489 494
39. Y Tian RY Ding YH Zhi RX Guo SD Wu 2006 Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity World J Gastroenterol 12 415 419 (Pubitemid 43329258)